Modern medical technologies are repairing the human body in ways never imagined only a few years ago, but they are leaving an increasing population of patients who are newly susceptible to opportunistic pathogens. Invasive and chronic fungal infections have become a formidable clinical opponent, and foremost among them is Aspergillus fumigatus, the focus of a [...]
GE Healthcare Lunar continues its strong record of continuously improving the customer experience and once again earned the top spot in MD Buyline’s 2nd quarter 2008 customer satisfaction survey on bone densitometry equipment and service. [...]
GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), announced a two-year cooperative research and development agreement with the National Cancer Institute (NCI) to accelerate the development of cutting-edge nanoparticle based imaging agents that have the potential to revolutionize the diagnosis and treatment of cancer and heart disease.
[...]
GE Healthcare, a unit of General Electric Company (NYSE:GE), announced that the Food and Drug Administration (FDA) has approved AdreView™ (Iobenguane I 123 Injection), a molecular imaging agent for the detection of rare neuroendocrine tumors in children and adults. AdreView provides high quality images that allow physicians to detect tumors, both at the time of [...]
Marauding molecules cause the tissue damage that underlies heart attacks, sunburn, Alzheimer’s and hangovers. But scientists at the Stanford University School of Medicine say they may have found ways to combat the carnage after discovering an important cog in the body’s molecular detoxification machinery.
Tags: ala, alcohol abuse, alcohol tolerance, alcoholism, alzheimer, [...]
(5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5)